Acoustic neuroma historical perspective

Jump to: navigation, search

Acoustic neuroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acoustic neuroma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

MRI

CT

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acoustic neuroma historical perspective On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acoustic neuroma historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acoustic neuroma historical perspective

CDC on Acoustic neuroma historical perspective

Acoustic neuroma historical perspective in the news

Blogs on Acoustic neuroma historical perspective

Directions to Hospitals Treating Acoustic neuroma

Risk calculators and risk factors for Acoustic neuroma historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2] Mohsen Basiri M.D.

Overview

Acoustic neuroma was first described by Eduard Sandifort , a professor of anatomy in the Netherlands, in 1777. Bilateral acoustic neuroma was first described by Wishart in 1822. He described a patient who became progressively deaf, blind, with uncontrollable vomiting and headaches, and facial jerking, and died at 21 years of age. Sir Charles Bell provided the first known report of a case of Meckel cave neuroma in 1833, demonstrating the relationship of the tumor to the cerebellopontine angle. Sir Charles Ballance successfully removed an acoustic neuroma in 1894, although the patient had right side facial paralysis and trigeminal anesthesia. Since then, tremendous efforts of many surgeons have been continuing to provide surgical approaches to improve outcomes of treatments and decrease side effects of interventions.

Historical Perspective

  • Acoustic neuroma was first described by Eduard Sandifort , a professor of anatomy in the Netherlands, in 1777.[1]
  • Bilateral acoustic neuroma was first reported by Wishart in 1822, in a patient who became progressively deaf, blind, had uncontrollable vomiting and headaches, and facial jerking. The patient died at 21 years of age. Wishart found numerous tumors in the skull at autopsy. He described the following: “The seventh cranial nerve pair was diseased in the same manner; a tumor of the size of a small nut, and very hard, being attached to each of them, just where they enter the meatus auditorius internus." [2]
  • In the most of the 18th century any surgery within dura eventuate in patient death, until understanding the role of bacteria, sepsis and development of anesthesia has been made in late 1800s. Sir Charles Ballance successfully removed an acoustic neuroma in 1894, although the patient had right side facial paralysis and trigeminal anesthesia, but the patient was alive and well, he reported.
  • Early in 1925 Dandy reported, operative mortality in acoustic neuroma was ranging from 67% to 84%, which it was extremely high. Harvey Cushing through increased experience and partial, intracapsular removal of the tumor was able to reduce the mortality rate to 11%.
  • Since of concerns of tumor regrowth, Walter Dandy suggested total removal of the tumor by intracapsular enucleation followed by “deliberate, painstaking dissection of the capsul” from the brainstem through a suboccipital approach, which became the standard technique for removing acoustic neuromas for the next 40 years. Although there were improvements in diagnosis and treatment, mortality rate was still high.[3]
  • Dr William House had developed the middle cranial fossa approach for decompensation of the internal auditory canal in 1960.He performed a series of cadaver sections to find a method to expose the cerebellopontine angle through mastoid to preserve the facial nerve, the tympanic membrane, and posterior canal wall which leads to development of translabyrinthine approach.[4]
  • In 1965 when the first international Symposium on Acoustic Neuroma was organized, for 5 days leading neurosurgeons, otologists, neurologists, and audilogists attended the meeting and covered a expanded range of subjects.
  • Over the years, it has become recognized all approaches include: retrosigmoid, middle fossa, and translabyrithine are valuable and the approach had to be selected depending on the size and location of the tumor as well as patient’s general condition and preoperative hearing condition.[5]

References

  1. Mariana Hausen Pinna, Ricardo Ferreira Bento & Rubens Vuono de Brito Neto (2012). "Vestibular schwannoma: 825 cases from a 25-year experience". International archives of otorhinolaryngology. 16 (4): 466–475. doi:10.7162/S1809-97772012000400007. PMID 25991975. Unknown parameter |month= ignored (help)
  2. J. H. Wishart (1822). "Case of Tumours in the Skull, Dura Mater, and Brain". Edinburgh medical and surgical journal. 18 (72): 393–397. PMID 30332030. Unknown parameter |month= ignored (help)
  3. S. I. Rosenberg (2000). "Natural history of acoustic neuromas". The Laryngoscope. 110 (4): 497–508. doi:10.1097/00005537-200004000-00002. PMID 10763994. Unknown parameter |month= ignored (help)
  4. Ashkan Monfared, Albert Mudry & Robert Jackler (2010). "The history of middle cranial fossa approach to the cerebellopontine angle". [[Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology]]. 31 (4): 691–696. doi:10.1097/MAO.0b013e3181c0e98e. PMID 19816222. Unknown parameter |month= ignored (help)
  5. Welling DB (1998). "Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas)". Laryngoscope. 108 (2): 178–89. PMID 9473065.

Linked-in.jpg